Helvet Health Agency was awarded earlier in 2017 **European Agency of Record** for bluebird bio, supporting the Global marketing team both in thalassemia  and cALD, two severe genetic diseases.

Helvet Health is working with bluebird bio to prepare European physicians and patients for what will certainly be&nbsp;a gene therapy revolution!

large_helvet-health-awarded.jpg

medium_helvet-health-awarded.jpg

small_helvet-health-awarded.jpg

thumbnail_helvet-health-awarded.jpg

helvet-health-awarded.jpg

Helvet Health Agency was awarded earlier in 2017 European Agency of Record for bluebird bio, supporting the Global marketing team both in thalassemia  and cALD, two severe genetic diseases.

News

Helvet Health wins bluebird bio EU Agency of Record gene replacement therapy in europe